$PNOW has filed its second quarter disclosures with the OTC Markets, revealing an additional reduction of $1 Million in interest from legacy debt, along with increased capital infusions intended to further the Company’s technology projects – including Oveedia’s completion.
(0)
(0)
Regenerative Medical Technology Group Inc. (RMTG) Stock Research Links